| Literature DB >> 26280898 |
Sebastian Demkowicz1, Mateusz Daśko1, Witold Kozak1, Katarzyna Krawczyk1, Dariusz Witt1, Maciej Masłyk2, Konrad Kubiński2, Janusz Rachon1.
Abstract
In the present work, we report the initial results of our study on a series of 3-phenylcoumarin sulfamate-based compounds containing C-F bonds as novel inhibitors of steroid sulfatase. The new compounds are potent steroid sulfatase inhibitors, possessing more than 10 times higher inhibitory potency than coumarin-7-O-sulfamate. In the course of our investigation, compounds 2b and 2c demonstrated the highest inhibitory effect on the enzymatic steroid sulfatase assay; both had IC50 values of 0.27 μm (the IC50 value of coumarin-7-O-sulfamate is 3.5 μm, used as a reference).Entities:
Keywords: breast cancer; coumarin; steroid sulfatase; steroid sulfatase inhibitors; sulfamates
Mesh:
Substances:
Year: 2015 PMID: 26280898 DOI: 10.1111/cbdd.12652
Source DB: PubMed Journal: Chem Biol Drug Des ISSN: 1747-0277 Impact factor: 2.817